By Deborah A. Kuban, MD, FASTRO, ROI President
The Radiation Oncology Institute (ROI) was pleased to announce two new research funding opportunities this spring. Our Research Committee has done a fantastic job developing the requests for proposals (RFPs) that we hope will inspire groundbreaking research with results that will improve practice and benefit our patients.
Our most recent RFP is designed to provide seed funding for the most innovative proposals that address any facet of the National Radiation Oncology Research Needs Assessment, a comprehensive assessment of research priorities for the field of radiation oncology commissioned by the ROI. Priority research areas include: communication, quality and safety, comparative effectiveness, toxicity management and value. All qualified investigators, including residents and fellows are eligible to apply for these grants. The deadline for submitting proposals for the “Innovative Projects in Radiation Oncology” RFP is July 22, 2016.
Our other current RFP is focused on exploring the possibilities for using “big data” to improve and personalize quality assurance. The award for the “Leveraging Big Data to Optimize Quality Assurance and Patient Care Improvement Initiatives” RFP will be up to $200,000 over two years. Letters of intent to submit a proposal are due on July 8, 2016 and invited proposals will be due on September 16, 2016.
More information about eligibility, how to apply and selection criteria for both of our current RFPs is available on the Funding Opportunities page on the ROI website.
The ROI Board of Trustees and I are very excited to see what the best and brightest minds in radiation oncology research will have to offer in response to these two RFPs. We look forward to sharing with you the award winners and their promising and innovative ideas later this year.
The ROI is a nonprofit, 501(c)(3) foundation created in 2006 by the ASTRO Board of Directors to support research and education efforts around the world that heighten the critical role of radiation therapy in the treatment of cancer. ROI strategically funds research on new and existing radiation therapy treatments to identify links between best practices and improved outcomes, to evaluate the efficacy and cost-benefit of radiation therapy and to foster multi-institutional research in radiation oncology. For more information, visit www.roinstitute.org
Our most recent RFP is designed to provide seed funding for the most innovative proposals that address any facet of the National Radiation Oncology Research Needs Assessment, a comprehensive assessment of research priorities for the field of radiation oncology commissioned by the ROI. Priority research areas include: communication, quality and safety, comparative effectiveness, toxicity management and value. All qualified investigators, including residents and fellows are eligible to apply for these grants. The deadline for submitting proposals for the “Innovative Projects in Radiation Oncology” RFP is July 22, 2016.
Our other current RFP is focused on exploring the possibilities for using “big data” to improve and personalize quality assurance. The award for the “Leveraging Big Data to Optimize Quality Assurance and Patient Care Improvement Initiatives” RFP will be up to $200,000 over two years. Letters of intent to submit a proposal are due on July 8, 2016 and invited proposals will be due on September 16, 2016.
More information about eligibility, how to apply and selection criteria for both of our current RFPs is available on the Funding Opportunities page on the ROI website.
The ROI Board of Trustees and I are very excited to see what the best and brightest minds in radiation oncology research will have to offer in response to these two RFPs. We look forward to sharing with you the award winners and their promising and innovative ideas later this year.
The ROI is a nonprofit, 501(c)(3) foundation created in 2006 by the ASTRO Board of Directors to support research and education efforts around the world that heighten the critical role of radiation therapy in the treatment of cancer. ROI strategically funds research on new and existing radiation therapy treatments to identify links between best practices and improved outcomes, to evaluate the efficacy and cost-benefit of radiation therapy and to foster multi-institutional research in radiation oncology. For more information, visit www.roinstitute.org
RSS Feed